
China Releases White Paper on COVID-19 Response and Origins
China releases a white paper detailing its COVID-19 actions and stance on virus origins, emphasizing global cooperation and scientific investigation.
News for people and friends

China releases a white paper detailing its COVID-19 actions and stance on virus origins, emphasizing global cooperation and scientific investigation.

An examination of the U.S. response to the COVID-19 pandemic, exploring criticisms and lessons learned from the country’s handling of the crisis.

China releases a white paper detailing its COVID-19 actions and global contributions, emphasizing cooperation and tracing the pandemic’s origins.

Lung cancer continues to be the leading cause of cancer deaths worldwide for the tenth year in a row. Early detection and prevention efforts are crucial in reversing this deadly trend.

Experts caution that new US tariffs on pharmaceuticals could raise drug prices, worsen shortages, and undermine global health systems.

On World Parkinson’s Day, explore the latest research and therapies offering hope in the fight against Parkinson’s disease, a brain disorder affecting millions globally.

China’s maternal and infant mortality rates have reached new lows in 2024, thanks to ongoing improvements in healthcare services across the country.

China has made significant strides in combating tuberculosis, with incidence and mortality rates dropping by 30%. Health authorities highlight the nation’s efforts as surpassing global averages in TB prevention and treatment.

Chinese doctor Dr. Li Liang volunteers as the first to receive a groundbreaking new mRNA tuberculosis vaccine, offering new hope in the fight against TB, especially in the Global South.

Hainan’s Boao Lecheng zone achieves China’s first import of special medical formula food, marking a milestone in healthcare innovation and international collaboration.